Theranostics 2022; 12(8):3601. doi:10.7150/thno.72666 This issue

Erratum

A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway: Erratum

Jun-Fang Zhang1,2,3*, Hua-Long Xiong1,2*, Jia-Li Cao1,2, Shao-Juan Wang1,2, Xue-Ran Guo1,2, Bi-Yun Lin4, Ying Zhang1,2, Jing-Hua Zhao1,2, Ying-Bin Wang1,2, Tian-Ying Zhang1,2,✉, Quan Yuan1,2,✉, Jun Zhang1,2, Ning-Shao Xia1,2

1. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, China;
2. National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, Xiamen University, Xiamen 361102, China;
3. School of Medicine, Shenzhen University, Shenzhen, 518060, China;
4. Department of Clinical Pathology, Affiliated Hospital of Guangdong Medical College, Zhanjiang, 524001, China.
* These authors contributed equally to this work

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Zhang JF, Xiong HL, Cao JL, Wang SJ, Guo XR, Lin BY, Zhang Y, Zhao JH, Wang YB, Zhang TY, Yuan Q, Zhang J, Xia NS. A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway: Erratum. Theranostics 2022; 12(8):3601. doi:10.7150/thno.72666. Available from https://www.thno.org/v12p3601.htm

File import instruction

Corrected-article in Theranostics, Volume 8, 549